FP

Flagship Pioneering Portfolio holdings

AUM $268M
This Quarter Return
+41.4%
1 Year Return
-54.4%
3 Year Return
-51.2%
5 Year Return
+66.7%
10 Year Return
–
AUM
$9.55B
AUM Growth
+$9.55B
Cap. Flow
-$666M
Cap. Flow %
-6.98%
Top 10 Hldgs %
99.02%
Holding
13
New
1
Increased
–
Reduced
1
Closed
–

Top Buys

1
OMGA
Omega Therapeutics, Inc. Common Stock
OMGA
$488M

Top Sells

1
MRNA icon
Moderna
MRNA
$1.15B

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MRNA icon
1
Moderna
MRNA
$9.37B
$6.77B 70.86%
17,581,016
-3,000,000
-15% -$1.15B
SANA icon
2
Sana Biotechnology
SANA
$777M
$771M 8.07%
34,239,018
– –
RUBY
3
DELISTED
Rubius Therapeutics, Inc
RUBY
$688M 7.21%
38,506,526
– –
OMGA
4
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$488M 5.11%
+25,902,269
New +$488M
FHTX icon
5
Foghorn Therapeutics
FHTX
$286M
$177M 1.85%
12,674,120
– –
EVLO
6
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$162M 1.7%
23,030,069
– –
DNLI icon
7
Denali Therapeutics
DNLI
$2.23B
$138M 1.44%
2,730,263
– –
KLDO
8
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$107M 1.12%
19,575,710
– –
MCRB icon
9
Seres Therapeutics
MCRB
$166M
$100M 1.05%
14,378,802
– –
SGTX
10
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$58.6M 0.61%
10,370,369
– –
CDAK
11
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$42.6M 0.45%
2,607,303
– –
AXLA
12
DELISTED
Axcella Health Inc. Common Stock
AXLA
$37.4M 0.39%
12,548,414
– –
SYRS
13
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$13.1M 0.14%
2,938,494
– –